EFTA00606967.pdf

41) Quest Diagnostics' —60 Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 63 Gender: M Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR911482U Requisition: 0021277 Collected: Received: Reported: Test Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL 06/24/2016 06/27/2016 10:03 EDT 06/27/2016 16:51 EDT Client #: 17436 56W5265 MOSKOWITZ, BRUCE W UCA/MOSKOWITZ BRUCE MD Attn: **P GR/UNIV.CLINICAL 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401 In Range Out Of Range Reference Range Lab 184 125-200 mg/dL MI 29 L > OR = 40 mg/dL MI 375 H <150 mg/dL MI 80 <130 mg/dL (talc) MI Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 6.3 H NON HDL CHOLESTEROL 155 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 1.1 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 14.2 H Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC PANEL GLUCOSE 90 < OR = 5.0 (talc) mg/dL (talc) mg/L <11.4 umol/L 65-99 mg/dL Fasting reference interval UREA NITROGEN (BUN) 24 7-25 mg/dL CREATININE 0.99 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 81 > OR = 60 mL/min/1.73m2 MI MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR911482U Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE I OF 5 EFTA00606967 rajQuest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 63 Gender: M Patient ID: 19530120MM Health ID: 8573003290851249 Specimen: MR9 I 1482U Collected: 06/24/2016 Received: 06/27/2016 / 10:03 EDT Reported: 06/27/2016 / 16:51 EDT Client #: 17436 MOSKOWITZ, BRUCE W Test Name eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM 9.6 PROTEIN, TOTAL 6.8 ALBUMIN 4.3 GLOBULIN 2.5 ALBUMIN/GLOBULIN RATIO 1.7 BILIRUBIN, TOTAL 0.8 ALKALINE PHOSPHATASE 56 AST 19 ALT 18 HEMOGLOBIN A1c 6.2 H According to ADA guidelines, hemoglobin Alc <7.0% represents optimal control in non-pregnant diabetic patients. Different metrics may apply to specific patient populations. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013:36:s11-s66 In Range 94 NOT APPLICABLE 138 4.3 104 Out Of 16 L For the purpose of screening for the presence of diabetes <5.7% 5.7-6.4% Range Consistent with the absence of diabetes Consistent with increased risk for diabetes (prediabetes) >or=6.5% Consistent with diabetes This assay result is consistent with a higher risk of diabetes. Currently, no consensus exists for use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 7.4 Therapeutic target for gout patients: <6.0 mg/dL TSH T4 (THYROXINE), TOTAL FREE T4 INDEX (T7) T3 UPTAKE SED RATE BY MODIFIED WESTERGREN CSC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT RED BLOOD CELL COUNT HEMOGLOBIN HEMATOCRIT MCV MCH MCHC RDW PLATELET COUNT MPV ABSOLUTE NEUTROPHILS ABSOLUTE LYMPHOCYTES 2.26 7.4 2.4 32 9 Reference Range > OR = 60 mL/min/1.73m2 6-22 (talc) 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 19-30 mmol/L 8.6-10.3 mg/dL 6.1-8.1 g/dL 3.6-5.1 g/dL 1.9-3.7 g/dL (talc) 1.0-2.5 (talc) 0.2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L <5.7 % of total Hgb 4.0-8.0 mg/dL 0.40-4.50 mIU/L 4.5-12.0 mcg/dL 1.4-3.8 22-35 % < OR - 20 mm/h 7.5 3.8-10.8 Thousand/uL 5.24 4.20-5.80 Million/uL 14.8 13.2-17.1 g/dL 44.5 38.5-50.0 % 84.9 80.0-100.0 fL 28.2 27.0-33.0 pg 33.2 32.0-36.0 g/dL 14.4 11.0-15.0 % 266 140-400 Thousand/uL 8.0 7.5-11.5 fL 4050 1500-7800 cells/uL 2438 850-3900 cells/uL Lab MI MI MI MI MI MI MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR9 I 1482U Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 5 EFTA00606968 Quest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 63 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR911482U Collected: 06/24/2016 Received: 06/27/2016 / 10:03 EDT Reported: 06/27/2016 / 16:51 EDT Client #: 17436 MOSKOWITZ, BRUCE W Test Name ABSOLUTE MONOCYTES ABSOLUTE EOSINOPHILS ABSOLUTE BASOPHILS NEUTROPHILS LYMPHOCYTES MONOCYTES EOSINOPHILS BASOPHILS URINALYSIS, COMPLETE See Endnote 2 FOLATE, SERUM In Range 480 495 38 54.0 32.5 6.4 6.6 0.5 Out Of Range Reference Range 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL 12.7 ng/mL Reference Range Low: <3.4 Borderline: 3.4-5.4 Normal: >5.4 C-REACTIVE PROTEIN 0.10 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.7 TESTOSTERONE, TOTAL, MALES (ADULT), IA 149 L Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than approximately 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. Two morning (8-10 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.5 Endnote 1 This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. * Test not performed. * No specimen received. * * 2.0-18.0 ng/mL 250-827 ng/dL < OR = 4.0 ng/mL Lab MI MI MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR911482U Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F5 EFTA00606969 rajQuest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 63 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR911482U Collected: 06/24/2016 Received: 06/27/2016 / 10:03 EDT Reported: 06/27/2016 / 16:51 EDT Client #: 17436 MOSKOWITZ. BRUCE W Endocrinology Test Name Result Reference Range Lab VITAMIN D,25.OH,TOTAL,IA 36 30-100 ng/mL MI Vitamin D Status Deficiency: Insufficiency: Optimal: 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http://education.questdiagnostics.com/faq/FAQ163 (This link is being provided for informational/educational purposes only.) Physician Comments: Infectious Diseases Test Name Result Reference Range Lab HIV 1/2 ANTIGEN/ANTIBODY, FOURTH GENERATION W/RFL MI HIV AG/AB, 4TH GEN I NON-REACTIVE I NON-REACTIVE HIV-1 antigen and HIV-1/HIV-2 antibodies were not detected. There is no laboratory evidence of HIV infection. PLEASE NOTE: This information has been disclosed to you from records whose confidentiality may be protected by state law. If your state requires such protection, then the state law prohibits you from making any further disclosure of the information without the specific written consent of the person to whom it pertains, or as otherwise permitted by law. A general authorization for the release of medical or other information is NOT sufficient for this purpose. For additional information please refer to http://education.questdiagnostics.com/faq/FAQ106 (This link is being provided for informational/ educational purposes only.) The performance of this assay has not been clinically validated in patients less than 2 years old. CLIENTSERVICES:866.697.8378 SPECIMEN: MR911482U PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00606970 rajQuest Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information EPSTEIN, JEFFREY Specimen: MR911482U Collected: 06/24/2016 DOB: 01/20/1953 AGE: 63 Received: 06/27/2016 / 10:03 EDT Gender: M Reported: 06/27/2016 / 16:51 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Infectious Diseases Client Information Client #: 17436 MOSKOWITZ, BRUCE W Test Name Result Reference Range Lab Physician Comments: Infectious Diseases Test Name Result Reference Range Lab HEPATITIS PANEL, ACUTE W/REFLEX TO CONFIRMATION HEPATITIS A IGM I NON-REACTIVE I NON-REACTIVE MI HEPATITIS B SURFACE ANTIGEN W/REFL CONFIRM MI HEPATITIS B SURFACE ANTIGEN NON-REACTIVE NON-REACTIVE HEPATITIS B CORE ANTIBODY (IGM) NON-REACTIVE NON-REACTIVE MI HEPATITIS CAB W/REFL TO HCV RNA, ON, PCR MI HEPATITIS C ANTIBODY NON-REACTIVE NON-REACTIVE SIGNAL TO CUT-OFF 0.02 <1.00 Physician Comments: PENDING TESTS: TESTOSTERONE, FREE LC/MS/MS PERFORMING SITE: MI QUEST DIAGNOSTICS.NIIAMI. I0RI0 COMMERCE PARKWAY. MIRAMAR. FL 3.360-5.3938 Laboraumy DINCIOI: GLEN L. NORM MD PHD. WA: I 0D0277334 CLIENT SERVICES: SPECIMEN: MR911482U Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 5 OF 5 EFTA00606971